Quantifying the duration of pre-diabetes

被引:72
作者
Bertram, Melanie Y. [1 ]
Vos, Theo [1 ]
机构
[1] Univ Queensland, Sch Populat Hlth, Ctr Burden Dis & Cost Effectiveness, Herston, Qld 4006, Australia
基金
英国医学研究理事会;
关键词
pre-diabetes; duration; epidemiology; screening; IMPAIRED FASTING GLUCOSE; LIFE-STYLE; CARDIOVASCULAR-DISEASE; PLASMA-GLUCOSE; MORTALITY; TOLERANCE; RISK; CRITERIA; OBESITY; AUSDIAB;
D O I
10.1111/j.1753-6405.2010.00532.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: Interventions for individuals with pre-diabetes are efficacious, however, identification of people with pre-diabetes does not occur in Australia. This study aims to calculate the duration of pre-diabetes, in order to provide supporting evidence for a screening program. Methods: We carried out a systematic review and random effects meta-analysis to identify if an increased risk of mortality is present in people with pre-diabetes. The result of this meta-analysis as well as information on prevalence, remission of pre-diabetes and transition to diabetes from an Australian cohort study, were used in the software program DisMod to calculate duration. Results: From 2,578 articles identified, 11 studies met the inclusion criteria. The pooled relative risk of all-cause mortality was 1.26 (1.17-1.34) with no sign of heterogeneity between the studies. The average duration of pre-diabetes was 8.5 years in males aged 30+ and 10.3 years in females aged 30+. Conclusions: The duration of pre-diabetes in Australia is long enough to warrant a screening program. The finding is robust to sensitivity testing of very large variations in the epidemiological parameters. Implications: If the interventions following screening are shown to be cost-effective, a strong rationale for the implementation of a screening program exists.
引用
收藏
页码:311 / 314
页数:4
相关论文
共 20 条
[1]  
[Anonymous], 1999, Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation
[2]  
[Anonymous], LANCET
[3]   Two hour plasma glucose is not unequivocally predictive for early death in men with impaired fasting glucose:: more results from the Paris Prospective Study [J].
Balkau, B ;
Forhan, A ;
Eschwège, E .
DIABETOLOGIA, 2002, 45 (09) :1224-1230
[4]   A generic model for the assessment of disease epidemiology: The computational basis of DisMod II [J].
Jan J Barendregt ;
Gerrit J van Oortmarssen ;
Theo Vos ;
Christopher JL Murray .
Population Health Metrics, 1 (1)
[5]   Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance - The Australian diabetes, obesity, and lifestyle study (AusDiab) [J].
Barr, Elizabeth L. M. ;
Zimmet, Paul Z. ;
Welborn, Timothy A. ;
Jolley, Damien ;
Magliano, Dianna J. ;
Dunstan, David W. ;
Cameron, Adrian J. ;
Dwyer, Terry ;
Taylor, Hugh R. ;
Tonkin, Andrew M. ;
Wong, Tien Y. ;
McNeil, John ;
Shaw, Jonathan E. .
CIRCULATION, 2007, 116 (02) :151-157
[6]  
Barr ELM., 2006, AusDiab 2005 The Australian diabetes
[7]  
de Rezende J, 1965, Rev Ginecol Obstet (Sao Paulo), V117, P23
[8]   DER PRADIABETES [J].
DITSCHUNEIT, H .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1965, 90 (43) :1925-+
[9]   The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) - methods and response rates [J].
Dunstan, DW ;
Zimmet, PZ ;
Welborn, TA ;
Cameron, AJ ;
Shaw, J ;
de Courten, M ;
Jolley, D ;
McCarty, DJ .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 57 (02) :119-129
[10]   Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis [J].
Gillies, Clare L. ;
Abrams, Keith R. ;
Lambert, Paul C. ;
Cooper, Nicola J. ;
Sutton, Alex J. ;
Hsu, Ron T. ;
Khunti, Kamlesh .
BMJ-BRITISH MEDICAL JOURNAL, 2007, 334 (7588) :299-302B